```

[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104159-104160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30482]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-25-24IV]

Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Comprehensive Evaluation of the 
Implementation and Uptake of the CDC Clinical Practice Guideline for 
Prescribing Opioids for Pain'' to the Office of Management and Budget 
(OMB) for review and approval. CDC previously published a ``Proposed 
Data Collection Submitted for Public Comment and Recommendations'' 
notice on October 1, 2024, to obtain comments from the public and 
affected agencies. There were two public comments related to the 
previous notice. This notice serves to allow an additional 30 days for 
public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding

[[Page 104160]]

the items contained in this notice to the Attention: CDC Desk Officer, 
Office of Management and Budget, 725 17th Street NW, Washington, DC 
20503 or by fax to (202) 395-5806. Provide written comments within 30 
days of notice publication.

Proposed Project

    Comprehensive Evaluation of the Implementation and Uptake of the 
CDC Clinical Practice Guideline for Prescribing Opioids for Pain--New--
National Center for Injury Prevention and Control (NCIPC), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    Beginning in the 1990s, opioid prescribing rates for pain 
management steadily increased until 2010, remained steady until 2012, 
and have declined since then. The increase in opioid prescribing rates 
corresponded with increases in opioid-involved overdose deaths, which 
initially primarily involved prescription opioids (natural and semi-
synthetic opioids and methadone). In response to this emerging crisis, 
CDC issued the CDC Guideline for Prescribing Opioids for Chronic Pain--
United States, 2016 (2016 CDC Guideline). Implementing the 2016 CDC 
Guideline was associated with reductions in opioid prescribing and 
increases in use of non-opioid medications for pain. At the same time, 
laws and policies related to prescribing opioids were instituted that 
misapplied or were inconsistent with the 2016 CDC Guideline, 
potentially contributing to patient harm. In 2022, CDC released the CDC 
Clinical Practice Guideline for Prescribing Opioids for Pain--United 
States, 2022, (2022 CDC Clinical Practice Guideline) which provided up 
to date evidence regarding pain management approaches and re-emphasizes 
the need for prescribers to be focused on patient-centered care to 
provide effective pain management. CDC is comprehensively evaluating 
the uptake, implementation, and outcomes of the 2022 CDC Clinical 
Practice Guideline on evidence-based care for pain management to 
understand its impact.
    To meet CDC's goal for a rigorous, comprehensive evaluation, this 
collection is proposing a mixed-method quasi-experimental approach to 
evaluate the 2022 CDC Clinical Practice Guideline. The evaluation 
includes dissemination and impact of the 2022 CDC Clinical Practice 
Guideline through population-wide changes in prescribing practices for 
opioids and medications for opioid use disorder. Also, evaluation of 
the implementation of the 2022 CDC Clinical Practice Guideline comes 
from perspectives of patients, caregivers, clinicians; and leaders from 
health systems, payers, professional associations, and medical boards.
    CDC will use this information collection to evaluate the 
dissemination, impact, and implementation of the 2022 CDC Clinical 
Practice Guideline to ensure that Americans have access to safer, 
effective ways of managing their pain. CDC requests OMB approval for an 
estimated 310 annual burden hours. There are no costs to respondents 
other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Clinicians............................  Clinician Survey........             200               1           10/60
                                        Invitation..............            1000               1            5/60
                                        Follow up Emails........            1000               1            5/60
                                        Clinician Interview.....              10               1               1
Dentists..............................  Dentist Interview.......               2               1               1
Health System Leaders.................  Health System Leaders                  3               2               1
                                         Interview.
Payers................................  Payer Interview.........               3               2               1
Professional Association Leaders......  Professional Association               3               2               1
                                         Leaders Interview.
Medical Board Leaders.................  Medical Board Leaders                  3               2               1
                                         Interview.
Patients..............................  Patient Focus Groups....              15               3               1
Caregivers............................  Caregiver Focus Groups..              15               2               1
----------------------------------------------------------------------------------------------------------------

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-30482 Filed 12-19-24; 8:45 am]
BILLING CODE 4163-18-P
```